Additional information
Grey colour Powder
191939-34-1
ACI-021717
–
C16H20ClN3O2S • HCl
390.33
Ambient
2-8°C
Chemotherapy
Pharmaceutical Impurity Standards
4-(6-(2-Chloroethyl)-3-methyl-3,6,7,8-tetrahydroimidazo[4',5':5,6]benzo[1,2-b][1,4]thiazin-2-yl)butanoic Acid Hydrochloride
4-(6-(2-Chloroethyl)-3-methyl-3,6,7,8-tetrahydroimidazo[4',5':5,6]benzo[1,2-b][1,4]thiazin-2-yl)butanoic Acid Hydrochloride
Imidazo[4,5-h][1,4]benzothiazine-2-butanoic acid, 6-(2-chloroethyl)-3,6,7,8-tetrahydro-3-methyl





![N-DEMETHYL BOSUTINIB (25 mg) (4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(piperazin-1-yl)propoxy]quinoline-3-carbonitrile )](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)